Physician profile
Shae B Paschal
NPI 1942431341
$2,024.07
in general payments reported to CMS, 2019-2025
23 companies · $166 in 2025
The $166 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $805 · 2020: $83.48 · 2021: $79.55 · 2022: $60.13 · 2023: $344 · 2024: $486 · 2025: $166.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $996.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $995.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $397.59 | 2021-2025 | Infinity Adaptis, Prostep Mica, Augment Injectable |
| Bone Support INC. | $292.47 | 2024 | Cerament G, Ceramentbone Void Filler |
| Smith+Nephew, INC. | $206.76 | 2019-2021 | |
| Melinta Therapeutics, LLC | $137.08 | 2019-2020 | |
| Integra Lifesciences Corporation | $119.75 | 2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Fusion Orthopedics USA, LLC | $109.20 | 2024 | |
| Abbott Laboratories | $107.42 | 2019 | |
| Wright Medical Technology, INC. | $89.29 | 2019-2020 | |
| Sandoz INC. | $84.65 | 2019 | |
| Misonix INC | $67.11 | 2019 | |
| Zyla Life Sciences, INC. | $49.95 | 2019 | |
| Osteomed LLC | $47.99 | 2019 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $45.75 | 2019-2025 | Jublia, Cabtreo |
| Averitas Pharma INC. | $44.73 | 2025 | Qutenza |
| Nevro Corp. | $37.71 | 2023 | Senza |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $37.47 | 2019 | |
| Bioventus LLC | $28.26 | 2025 | |
| Reprise Biomedical, INC. | $27.54 | 2023 | Miro3d |
| Tactile Systems Technology INC | $25.29 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $22.47 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $16.99 | 2025 | Exparel |
| Polynovo North America LLC | $14.58 | 2025 | Novosorb Btm |
| Orthofix Medical, INC. | $14.02 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shae Paschal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.